J. Harting

发表

The binding of diphosphopyridine nucleotide by glyceraldehyde-3-phosphate dehydrogenase.

J. E. Hayes, S. Velick, J. Harting, 1953, The Journal of biological chemistry.

A pharmacological profile of the novel, peripherally‐selective k‐opioid receptor agonist, EMD 61753

H. M. Bender, R. Murray, J. Harting, 1994, British journal of pharmacology.

Ischemic preconditioning is not a function of stunned myocardium

W. Schaper, J. Harting, S. Rohmann, 1991 .

Effect of isomazole on the responsiveness to calcium of the contractile elements in skinned cardiac muscle fibres of various species.

J. Harting, I. Lues, R. Siegel, 1988, European journal of pharmacology.

High &bgr;1‐Selectivity and Favourable Pharmacokinetics as the Outstanding Properties of Bisoprolol

C. Schmitges, J. Harting, C. Seyfried, 1985, Journal of cardiovascular pharmacology.

Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.

J. Harting, H. Schliep, 1984, Journal of cardiovascular pharmacology.

Antagonistic effects of bisoprolol on several beta-adrenoceptor-mediated actions in anaesthetized cats.

J. Harting, G. Haeusler, H. Schliep, 1986, European journal of pharmacology.

Cyclic hexapeptide NK-2 antagonists.

J. Harting, H. Greiner, G. Hölzemann, 2009, International journal of peptide and protein research.

Pharmacodynamic profile of the selective beta 1-adrenoceptor antagonist bisoprolol.

J. Harting, R. Jonas, K. Minck, 1986, Arzneimittel-Forschung.

Transfer reactions of acetyl phosphate catalyzed by glyceraldehyde-3-phosphate dehydrogenase.

S. Velick, J. Harting, 1954, The Journal of biological chemistry.

3-Methyl-2H-1-benzopyran potassium channel activators.

J. Harting, I. Lues, R. Gericke, 1991, Journal of medicinal chemistry.

Comparative conformational analysis and in vitro pharmacological evaluation of three cyclic hexapeptide NK-2 antagonists.

D. Leibfritz, R. Brunne, U. Wollborn, 2009, International journal of peptide and protein research.

Effects of receptor‐selective neurokinin agonists and a neurokinin antagonist on the electrical activity of spinal cord neurones in culture

M. Wienrich, J. Harting, K. Reuss, 1989, British journal of pharmacology.

Evidence for at Least Two Tachykinin Receptor Subtypes in the Mammalian Spinal Cord

M. Wienrich, J. Harting, I. Lues, 1987 .

Assessment of neuroleptic-like properties of progesterone

M. Koch, R. Spanagel, R. Rupprecht, 1999, Psychopharmacology.

Central and peripheral actions of the novel κ‐opioid receptor agonist, EMD 60400

R. Murray, J. Harting, C. Seyfried, 1994 .

Antinociceptive effects of the 5-HT2 antagonist ritanserin in rats: Evidence for an activation of descending monoaminergic pathways in the spinal cord

J. Harting, A. Barber, H. Wolf, 1989, Neuroscience Letters.

Do substance P agonists insert into the lipid membrane?

G. Barnickel, A. Seelig, J. Harting, 1992, Regulatory Peptides.

Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.

J. Harting, G. Bartoszyk, K. Minck, 1996, Journal of Pharmacology and Experimental Therapeutics.

Acetyl phosphate formation catalyzed by glyceraldehyde-3-phosphate dehydrogenase.

S. Velick, J. Harting, 1954, The Journal of biological chemistry.

Inhibition of cleavage and P32 uptake in Arbacia by d-usnic acid.

J. Harting, A. Marshak, 1948, Journal of cellular and comparative physiology.